DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Study Evaluating Vancomycin-Resistant Enterococci in a Hematology Unit

Information source: Wyeth is now a wholly owned subsidiary of Pfizer
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Gram-Positive Bacterial Infections

Intervention: Piperacillin/tazobactam and other β-lactam/β-lactamase (Drug)

Phase: Phase 4

Status: Completed

Sponsored by: Wyeth is now a wholly owned subsidiary of Pfizer

Official(s) and/or principal investigator(s):
Medical Monitor, Study Director, Affiliation: Wyeth is now a wholly owned subsidiary of Pfizer


To determine the impact of the restriction of the third and forth generation cephalosporins on the reduction of intestinal colonization or infection with vancomycin-resistant enterococci (VRE) in a surgical intensive care unit (SICU)

Clinical Details

Official title: Effects on the Emergence and Transmission of Vancomycin-Resistant Enterococci After Changes in Antibiotic Use in a Hematology Unit.

Study design: Observational Model: Case Control, Time Perspective: Longitudinal


Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- All patients admitted to or transferred to the SICU.

- Eligible patients will be patients of either sex, 18 years of age or older who are

admitted or transferred to the SICU.

- Provide written informed consent

Exclusion Criteria:

- Patients who have hypersensitivity to penicillin, cephalosporins or beta-lactamase


- Females who are pregnant and breast feeding

- Any underlying conditions or non-infectious diseases that will be ultimately fatal

within 48 hours.

- Those who have already been participating other clinical study related with


Locations and Contacts

Incheon 405-760, Korea, Republic of

Ulsan 682-714, Korea, Republic of

Additional Information

Starting date: January 2005
Last updated: March 14, 2007

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017